中外医疗
中外醫療
중외의료
China Foreign Medical Treatment
2015年
29期
134-135,138
,共3页
慢性阻塞性肺病%急性发作期%痰热清注射液%辅助治疗
慢性阻塞性肺病%急性髮作期%痰熱清註射液%輔助治療
만성조새성폐병%급성발작기%담열청주사액%보조치료
Chronic obstructive pulmonary disease%Acute exacerbation%Tanreqing injection%Adjuvant therapy
目的:探讨并分析痰热清注射液辅助治疗慢性阻塞性肺病急性发作的临床疗效。方法整群选取该院2014年6月—2015年6月收治的78例慢性阻塞性肺病患者,采用随机数字表法分为观察组与对照组,每组各39例,对照组患者给予头孢哌酮钠舒巴坦钠治疗,观察组患者在对照组患者治疗的基础上给予痰热清注射液辅助治疗,对比两组患者治疗的疗效。结果观察组患者治疗有效为94.87%,对照组患者治疗有效率为76.92%,观察组明显优于对照组,两组患者对比差异有统计学意义(P<0.05)。结论慢性阻塞性肺疾病急性发作期患者应用痰热清注射液辅助治疗具有良好的临床疗效,可在很大程度上提升临床治疗的有效率,安全性较高,且无明显不良反应,值得临床广泛应用与推广。
目的:探討併分析痰熱清註射液輔助治療慢性阻塞性肺病急性髮作的臨床療效。方法整群選取該院2014年6月—2015年6月收治的78例慢性阻塞性肺病患者,採用隨機數字錶法分為觀察組與對照組,每組各39例,對照組患者給予頭孢哌酮鈉舒巴坦鈉治療,觀察組患者在對照組患者治療的基礎上給予痰熱清註射液輔助治療,對比兩組患者治療的療效。結果觀察組患者治療有效為94.87%,對照組患者治療有效率為76.92%,觀察組明顯優于對照組,兩組患者對比差異有統計學意義(P<0.05)。結論慢性阻塞性肺疾病急性髮作期患者應用痰熱清註射液輔助治療具有良好的臨床療效,可在很大程度上提升臨床治療的有效率,安全性較高,且無明顯不良反應,值得臨床廣汎應用與推廣。
목적:탐토병분석담열청주사액보조치료만성조새성폐병급성발작적림상료효。방법정군선취해원2014년6월—2015년6월수치적78례만성조새성폐병환자,채용수궤수자표법분위관찰조여대조조,매조각39례,대조조환자급여두포고동납서파탄납치료,관찰조환자재대조조환자치료적기출상급여담열청주사액보조치료,대비량조환자치료적료효。결과관찰조환자치료유효위94.87%,대조조환자치료유효솔위76.92%,관찰조명현우우대조조,량조환자대비차이유통계학의의(P<0.05)。결론만성조새성폐질병급성발작기환자응용담열청주사액보조치료구유량호적림상료효,가재흔대정도상제승림상치료적유효솔,안전성교고,차무명현불량반응,치득림상엄범응용여추엄。
Objective To probe into and analyze the clinical effects of chronic obstructive pulmonary disease cured by tan-reqing injection. Methods 78 patients who suffered from the chronic obstructive pulmonary disease and who accepted treat-ments in our hospital from June, 2014 to June, 2015 were taken as the research objects, and these patients were randomly divided into the control group and the observation group, with 39 patients in each group. In the control group, they were giv-en the Cefoperazone Sulbactam Sodium while in the observation group, on the basis of the treatment in the control group, they were treated with the tanreqing injection. Then, the curing effects of these two groups of patients were compared. Results The response rate in the observation group was 94.87%, and the response rate in the control group was 76.92%, and the ob-servation group was significantly better than the control group , the differences had the statistical significance ( P<0 . 05 ) . Conclusion Theclinical effects of Chronic obstructive pulmonary disease cured by tanreqing injection are enough good, which can improve the clinical effect, it is safety and no obvious adverse reactions, thus should be promoted in the clinical application.